PUBLIC PROCUREMENT NOTICEExternal opportunity
Translated into EnglishAI translation · verify material terms against the original
AI-translated presentation
Spain – Pharmaceutical products – Supply of medicines with active ingredients: INTERFERON BETA 1-A, CANNABINOL-RONABINOL AND AVELUMAB, dispensed at the University Hospital under INGESA for patients of the Melilla Healthcare Management Authority.
Supply of medicines with active ingredients: Interferon Beta 1-A, Cannabinol-Ronabinol and Avelumab, dispensed at the University Hospital under INGESA for patients of the Melilla Healthcare Management Authority. MEDIC
Opportunity description
Supply of medicines with active ingredients: Interferon Beta 1-A, Cannabinol-Ronabinol and Avelumab, dispensed at the University Hospital under INGESA for patients of the Melilla Healthcare Management Authority. MEDICINE INTERFERON BETA 1-A Medicine Avelumab Procedure: open. Estimated value: 532,917.48 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Buyer Sign in to view
Response deadline Sign in to view
Delivery Sign in to view
Estimated value Sign in to view
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.